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Section A. General Methods 
All reagents were purchased from commercial suppliers and used without further purification. Thin 
layer chromatography (TLC) was performed on silica gel 60 F254 (E. Merck). Column 
chromatography was carried out on silica gel 60F (Merck 9385, 0.040–0.063 mm). UV-Vis Spectra 
were recorded at room temperature on a Shimadzu UV-3600 spectrophotometer. Fluorescence 
quantum yield was acquired using HORIBA Nanolog spectrofluorimeter and perylene in EtOH as 
reference. All samples were dissolved in CH2Cl2 and the excitation wavelength was 420 nm. 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance III 500 MHz and 
600 MHz spectrometers, with working frequencies of 600 and 500 MHz (1H NMR), respectively, 
and at 150 and 125 MHz (13C NMR), respectively. Chemical shifts were reported in ppm relative 
to the signals corresponding to the residual non-deuterated solvents (CD3CN: δH = 1.94 ppm and 
δC = 118.26 ppm; CDCl3: δH = 7.26 ppm and δC = 77.16 ppm; CD3SOCD3: δH = 2.50 ppm and δC 
= 39.52 ppm; (CD3)2NCOD: δH = 2.75, 2.92, and 8.03 ppm and δC = 29.76, 34.89, and 163.15 
ppm). High-resolution mass spectra were measured on an Agilent 6210 Time-of-Flight (TOF) LC-
MS, using an ESI source, coupled with Agilent 1100 HPLC stack, using direct infusion (0.6 
mL/min). Measurements at X-band (9.5 GHz) were performed with a Bruker Elexsys E580, 
equipped with a variable Q dielectric resonator (ER-4118X-MD5-W1). Single crystal X-ray 
diffraction data were collected using a Bruker diffractometer equipped with a Kappa goniometer, 
microfocus CuKa source, MX optics, and an Apex2 CCD area detector. Elaborations on the above 
experimental details are provided below in the appropriate sections. 
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Section B. Synthetic Protocols 
1) Synthesis of the 5,10,15,20-tetrakis(3-(bromomethyl)phenyl)porphyrin (bzTPP) 
 
Scheme S1. Synthesis of the bzTPP 
 
3-(Bromomethyl)benzaldehyde (1.9 g, 10 mmol) and pyrrole (0.7 mL, 10 mmol) were dissolved 
in a mixture of EtOH (5 ml) and CH2Cl2 (700 mL). The solution was deoxygenated under a stream 
of N2 for 15 min. BF3OEt2 (0.37 ml, 3 mmol) was added, immediately turning the solution a golden 
yellow color. The reaction was protected from light and stirred for 3 h, then DDQ (1.7 g, 7.5 mmol) 
was added and stirring continued for a further 1 h. The reaction was neutralized with Et3N (0.55 
mL, 4 mmol) and the solution condensed under reduced pressure. The crude mixture was purified 
on silica eluting with CH2Cl2. The solvent was removed on a rotary evaporator to yield the product 
as a purple-black microcrystalline solid (750 mg, 30%). 1H NMR (500 MHz, CDCl3, ppm): δ 8.89 
(s, 8H), 8.28 (s, 4H), 8.18 (d, J = 7.4 Hz, 4H), 7.83 (d, J = 7.9 Hz, 4H), 7.74 (t, J = 7.7 Hz, 4H), 
4.79 (s, 8H), –2.77 (s, 2H). 13C NMR (126 MHz, CDCl3, ppm): δ 142.7, 136.6, 135.2, 134.7, 128.6, 
127.4, 119.7, 33.7. ESI-HRMS for bzTPP; Calcd for C48H35Br4N4: m/z = 986.9554 [M + H]+; 
found: 986.9546. 
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2) Synthesis of the TB•4PF6 
 
Scheme S2. Synthesis of the TB•4PF6 
4,4'-Bipyridine (20.0 equiv, 15.6g, 10 mmol) was added to a solution of bzTPP (491mg, 0.5 mmol) 
in DMF (100 mL). After heating at 120 °C for 1 d, the mixture was cooled to room temperature 
and concentrated on a rotary evaporator under reduced pressure. The mixture was poured into 
CH2Cl2, and the resulted precipitate was collected by filtration and washed with CH2Cl2. Next, the 
purple solid was dissolved in H2O and the insoluble brown solid removed upon filtration. 
Counterion exchange was accomplished by the addition of aqueous saturated NH4PF6 solution, 
resulting in the precipitation of pure TB•4PF6 (785 mg, 84%) that was collected by filtration as a 
purple solid. 1H NMR (500 MHz, CD3CN, ppm): δ 9.03 (d, J = 4.7 Hz, 8H), 8.87 – 8.83 (m, 16H), 
8.38 – 8.27 (m, 16H), 7.96 – 7.90 (m, 8H), 7.78 – 7.76 (m, 8H), 6.05 (s, 8H), -2.95 (s, 2H). 13C 
NMR (125 MHz, CD3CN, ppm): δ 155.6, 152.1, 146.1, 143.7, 142.1, 136.5, 135.5, 132.8, 129.8, 
129.1, 127.3, 122.8, 120.3, 65.1. ESI-HRMS for TB•4PF6; Calcd for C88H66F12N12P2: m/z = 
790.7419 [M – 2 PF6]2+; found: 790.7416.   
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3) Synthesis of the TPPCage•8PF6 
 
 
 
Scheme S3. Synthesis of the TPPCage•8PF6 
 
A solution of TB•4PF6  (187 mg, 0.1 mmol, 1 equiv), bzTPP (98 mg, 0.1 mmol, 1 equiv), and 
tetra-n-butylammonium iodide (TBAI, 7 mg, 0.2 equiv) in dry MeCN (150 mL) was stirred at 
110 °C for 3 d. After cooling down to room temperature, the resulting precipitate was collected by 
centrifugation. The green solid was dissolved in H2O, followed by the addition of aqueous 
saturated NH4PF6 solution, resulting in the precipitation of TPPCage•8PF6 (59 mg, 19%) which 
was collected by centrifugation as a green solid. 1H NMR (500 MHz, (CD3)2NCDO, ppm) δ 9.63 
(d, J = 6.7 Hz, 16H), 8.88 (s, 16H), 8.65 (d, J = 6.7 Hz, 16H), 8.36 (d, J = 7.5 Hz, 8H), 8.25 (d, J 
= 8.0 Hz, 8H), 8.22 (s, 8H), 8.05 – 8.02 (m, 8H), 6.51 (s, 16 H), -3.20 (s, 4 H). 13C NMR (125 
MHz, (CD3)2NCDO, ppm): δ 150.9, 147.5, 143.6, 137.6, 136.1, 133.1, 131.2, 129.3, 128.1, 120.6, 
65.2. ESI-HRMS for TPPCage•8PF6; Calcd for C136H100F48N16P8: m/z = 1413.8095 [M – 2 PF6]2+; 
found: 1413.8092.  
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Section C. NMR Spectroscopy 
1) 1H NMR Spectra of TPPCage•8PF6 
 
 
Figure S1. 1H NMR Spectrum (500 MHz, DMF-d7, 298 K) of TPPCage•8PF6. 
 
2) 13C NMR Spectra of TPPCage•8PF6 
 
Figure S2. 13C NMR Spectrum (125 MHz, DMF-d7, 298 K) of TPPCage•8PF6. 
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3) 2D NMR Spectra of TPPCage•8PF6 
 
Figure S3. 1H-1H gCOSY NMR Spectrum (500 MHz, DMF-d7, 298 K) of TPPCage•8PF6.  
  
 
 
 
Figure S4. 1H-1H NOESY NMR Spectrum (500 MHz, DMF-d7, 298 K) of TPPCage•8PF6.  
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Figure S5. 1H-13C HSQC NMR Spectrum (DMF-d7, 298 K) of TPPCage•8PF6. 
 
 
Figure S6. 1H-13C HMBC NMR Spectrum (DMF-d7, 298 K) of TPPCage•8PF6. 
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Section D. Host-Guest Studies of Complex of Fullerene⊂TPPCage•8PF6 
1) General Procedure for Fullerene Encapsulation   
Fullerene was added to a solution of TPPCage•8PF6 in DMF-d7 (3.1 mg, 2 mM). After sonication 
at room temperature for 2 h, the undissolved solids were removed by centrifugation. The resulting 
solution was characterized by NMR spectroscopy and high-resolution mass spectrometry (HR-
ESI). 
 
2) Characterization for C60 ÌTPPCage•8PF6 Complex 
3.0 equiv of C60 was added to a solution of TPPCage•8PF6 in DMF-d7 (3.1 mg, 2 mM). The 
encapsulation was not complete even with excess of C60, resulting a mixture of 
C60ÌTPPCage•8PF6 and TPPCage•8PF6 in the solution.  
C60ÌTPPCage•8PF6: 1H NMR (500 MHz, (CD3)2NCDO, ppm) δ 9.75 (d, J = 6.6 Hz, 16H), 8.81 
(s, 16 H), 8.72 (d, J = 6.6 Hz, 8H), 8.44 (d, J = 7.5 Hz, 8H), 8.26 – 8.22 (m, 8H), 8.07 (t, J = 7.7 
Hz, 8H), 7.42 (s, 8H), 6.60 (s, 16H), -3.28 (s, 4H). 13C NMR (125 MHz, (CD3)2NCDO, ppm): δ 
151.0, 148.0, 144.1, 139.9, 136.6, 133.1, 132.4, 129.2, 128.3, 120.5, 65.2. 
ESI-HRMS for C60ÌTPPCage•8PF6; Calcd for C196H100F36N16P62+: m/z = 1774.3112 [M – 2 PF6]2+; 
found: 1774.3122. 
Figure S7. Stacked 1H NMR Spectra (500 MHz, DMF-d7, 298 K) Comparison of 
TPPCage•8PF6 and C60ÌTPPCage•8PF6. 	
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Figure S8. Stacked 13C NMR Spectra (125 MHz, DMF-d7, 298 K) Comparison of C60, 
TPPCage•8PF6 and C60ÌTPPCage•8PF6. 
 
Figure S9. 1H-1H gCOSY NMR Spectrum (500 MHz, DMF-d7, 298 K) of TPPCage•8PF6 
& C60ÌTPPCage•8PF6 mixture.  
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Figure S10. 1H-1H NOESY NMR Spectrum (500 MHz, DMF-d7, 298 K) of TPPCage•8PF6 
& C60ÌTPPCage•8PF6 mixture.  
 
Figure S11. 1H-13C HSQC NMR Spectrum (DMF-d7, 298 K) of TPPCage•8PF6 & 
C60ÌTPPCage•8PF6 mixture.  
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Figure S12. 1H-13C HMBC NMR Spectrum (DMF-d7, 298 K) of TPPCage•8PF6 & 
C60ÌTPPCage•8PF6 mixture. 
 
3) Characterization for C70ÌTPPCage•8PF6 Complex 
1.0 equiv of C70 was added to a solution of TPPCage•8PF6 in DMF-d7 (3.1 mg, 2 mM). The 
encapsulation was complete, resulting a solution of C70ÌTPPCage•8PF6 complex. 
 
C70ÌTPPCage•8PF6: δ 9.76 (d, J = 6.7 Hz, 16H), 8.89 (d, J = 6.7 Hz, 16H), 8.79 (s, 16 H), 8.32 
(d, J = 7.5 Hz, 8H), 8.25 (d, J = 8.0 Hz, 8H), 8.05 – 8.02 (m, 8H), 7.65 (s, 8H), 6.61 (s, 16H), -
3.73 (s, 4H). 13C NMR (125 MHz, (CD3)2NCOD, ppm): δ 150.7, 149.2, 148.0, 145.4, 1445.0, 
144.0, 141.8, 137.6, 133.0, 132.8, 131.7, 129.2, 128.4, 127.0, 120.6, 65.4. ESI-HRMS for 
C70ÌTPPCage•8PF6; Calcd for C206H100F36N16P62+: m/z = 1834.3112 [M – 2 PF6]2+; found: 
1834.3094. 
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Figure S13. Stacked 1H NMR Spectra (500 MHz, DMF-d7, 298 K) Comparison of 
TPPCage•8PF6 and C70ÌTPPCage•8PF6.  
 
Figure S14. Stacked 13C NMR Spectra (125 MHz, DMF-d7, 298 K) Comparison of C70, 
TPPCage•8PF6 and C70ÌTPPCage•8PF6.  
 
Compound δ / ppm 
Free C70 150.6 148.0 147.3 145.2 130.8 
C70 in complex 149.2 145.4 145.0 144.0 127.0 
 
Table S1. Chemical shift comparison between free C70 and C70 in complex in 13C NMR 
Spectra at 298 K (125 MHz, DMF-d7, ~1 mM for TPPCage•8PF6)  
	 S14 
 
Figure S15. Stacked 1H NMR Spectra (500 MHz, DMF-d7, 298 K) Comparison of 
TPPCage•8PF6, C70ÌTPPCage•8PF6 (complete encapsulation) and a mixture of 
TPPCage•8PF6 and C70ÌTPPCage•8PF6 (90% encapsulation), indicating a slow 
exchange in DMF at room temperature (~1 mM for TPPCage•8PF6).  
 
 
Figure S16. 1H-1H gCOSY NMR Spectrum (500 MHz, DMF-d7, 298 K) of 
C70ÌTPPCage•8PF6. 
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Figure S17. 1H-1H NOESY NMR Spectrum (500 MHz, DMF-d7, 298 K) of 
C70ÌTPPCage•8PF6. 
 
Figure S18. 1H-13C HSQC NMR Spectrum (DMF-d7, 298 K) of C70ÌTPPCage•8PF6. 
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Figure S19. 1H-13C HMBC NMR Spectrum (DMF-d7, 298 K) of C70ÌTPPCage•8PF6. 
4) Selective Extraction of C70 
A mixture of fullerene C60 (10 µmol) and C70 (1 µmol) was added to a solution of TPPCage•8PF6 
in DMF-d7 (1 µmol, 3.1 mg, 2 mM). The selective encapsulation of C70 was achieved, resulting in 
a solution of C70ÌTPPCage•8PF6 complex. 
 
Figure S20. Stacked 1H NMR Spectra (500 MHz, DMF-d7, 298 K) Comparison of 
TPPCage•8PF6, TPPCage•8PF6 & C60ÌTPPCage•8PF6, C70ÌTPPCage•8PF6, and C70 
Extraction Solution. 
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Figure S21. Stacked 13C NMR Spectra (125 MHz, DMF-d7, 298 K) Comparison of 
TPPCage•8PF6, TPPCage•8PF6 & C60ÌTPPCage•8PF6, C70ÌTPPCage•8PF6, and C70 
Extraction Solution. 
Section E. DOSY NMR Experiment  
A DOSY NMR experiment was carried out with Bruker Avance III 600 MHz spectrometer. The 
effective hydrodynamic radius R was calculated from the Stokes-Einstein equation, 
D=(kBT)/(6πηr), where D is the diffusion coefficient, kB is the Boltzmann constant, T is the absolute 
temperature, and η is the viscosity of the DMF-d7 (0.86 mPa·s). 
 
1) TPPCage•8PF6  
The measured diffusion coefficient is 2.12 × 10-6 cm2s-1, and the hydrodynamic radius of 
TPPCage•8PF6 is calculated to be 12.0 Å. 
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Figure S22. gDOSY NMR Spectrum (600 MHz, DMF-d7, 298 K) of TPPCage•8PF6. 
 
 
2) C60 Ì TPPCage•8PF6  
The measured diffusion coefficient is 2.09 E-6 cm2s-1, and the hydrodynamic radius of 
C60ÌTPPCage•8PF6 is calculated to be 12.1 Å. 
 
Figure S23. gDOSY NMR Spectrum (600 MHz, DMF-d7, 298 K) of C60ÌTPPCage•8PF6 
and TPPCage•8PF6 mixture. 
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3) C70 Ì TPPCage•8PF6  
The measured diffusion coefficient is 2.10 E-6 cm2s-1, and the hydrodynamic radius of 
C70ÌTPPCage•8PF6 is calculated to be 12.1 Å. 
 
Figure S24. gDOSY NMR Spectrum (600 MHz, DMF-d7, 298 K) of C70ÌTPPCage•8PF6. 
Section F. Binding Constant Determination  
1) NMR Spectra Integration of TPPCage•8PF6 and C60ÌTPPCage•8PF6  
The binding constant (Ka) for the formation of C60ÌTPPCage•8PF6 complex in DMF was 
determined by NMR spectroscopy from 3 parallel experiments. An excess of C60 (3.0 equiv) was 
added to a solution of TPPCage•8PF6 in DMF-d7 (0.5 mM, 1 mM, 2 mM). After sonication for 2 
h, the mixture was allowed to stand at room temperature for another 5 h to make sure it reached 
equilibrium. The undissolved solids were removed by centrifugation, resulting a solution of 
C60ÌTPPCage•8PF6 and TPPCage•8PF6 (the encapsulation was not complete even with large 
excess of C60). The binding constant was calculated based on equation  
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Ka = [C60ÌTPPCage•8PF6] / ([TPPCage•8PF6] × [C60]) 
 where [C60ÌTPPCage•8PF6] / [TPPCage•8PF6] can be obtained from NMR spectra integration 
(average of signal Ha, Hb, H6, HCH2), and the concentration of saturated C60 in DMF can be 
measured from UV-Vis spectra.S1  
Table S2. Binding Constant Determination for C60ÌTPPCage•8PF6. 
[C60] a 1.58 × 10-4 M 
[C60ÌTPPCage•8PF6] / ([TPPCage•8PF6] b 0.64 0.77 0.72 
Average Ratio c 0.71 
Ka (4.5 ± 0.4) × 103 M-1 
 
a C60 is saturated in DMF in all 3 experiments, and the concentration was measured from its UV-
Vis spectra. b The ratio between C60ÌTPPCage•8PF6 complex and empty TPPCage•8PF6 was 
calculated according to NMR spectra integration. c Average ratio calculated from 3 parallel 
experiments.  
 
2) UV-Vis Titration of TPPCage•8PF6 with C70 
The binding constant (Ka) for the formation of C70ÌTPPCage•8PF6 complex in DMF was 
determined by UV titration on a Shimadzu UV-3600 spectrophotometer using 0.2 cm UV cuvette. 
The concentrated solution of C70 (1 mM in PhMe) was added incrementally to the solution 
TPPCage•8PF6 (10 µM in DMF). The UV-Vis spectra were recorded one after the other. The 
stacked spectra (Figure S25) show that, upon the addition of C70, the absorption band on centered 
on 419 nm was reduced and slightly shifted to 422 nm. From the UV-Vis titration experiment, a 
plot (Figure S25, black dot) of absorption intensity at 419-422 nm against the equiv of C70 was 
	 S21 
obtained and a non-linear least squares data treatmentS2 (Figure S25, red line) gave an association 
constant of (2.4 ± 0.2) × 105 M-1.  
 
Figure S25. UV-Vis Spectrophotometric monitoring of the titration of a solution of 
TPPCage•8PF6 (10 µM in DMF) with C70 (1 mM in PhMe) in a 0.2 cm path cuvette. Inset: 
plot of ΔA422 nm vs equivalents of C70 added. The association constants modeled with 
a 1:1 equilibrium are KC70ÌTPPCage= (2.4 ± 0.2) × 105 M-1. 
Section H. Crystallographic Characterization  
All crystallographic data are available free of charge from the Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
1) TPPCage•8PF6 
a) Methods. TPPCage•8PF6 (2 mg) was dissolved in MeCN (1.0 mL) and the mixture was passed 
through a 0.45-µm filter into VWR culture tubes. The tubes were placed in one 20-mL vial 
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containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the solution 
of TPPCage•8PF6 in MeCN (0.6 mM) over the course of 4 d yielded brown needle-like single 
crystals of TPPCage•8PF6. A suitable crystal was selected and the crystal was mounted on a 
MITIGEN holder in Paratone oil on a Kappa Apex 2 diffractometer. The crystal was kept at 99.99 
K during data collection. Using Olex2S3, the structure was solved with the ShelXTS4 structure 
solution program using Intrinsic Phasing and refined with the XLS5 refinement package using Least 
Squares minimization. The solid-state structure of TPPCage•8PF6 is shown in Figure S26a. 
b) Crystal data. Monoclinic, space group P21/c (no. 14), a = 15.8431(11), b = 16.2840(10), c = 
34.474(2) Å, β = 91.307(4)°, V = 8891.6(10) Å3, Z = 2, T = 99.99 K, µ(CuKα) = 1.654 mm-1, Dcalc 
= 1.318 g/mm3, 45595 reflections measured (7.468 ≤ 2Θ ≤ 127.59), 14527 unique (Rint = 0.0495, 
Rsigma = 0.0512) which were used in all calculations. The final R1 was 0.0925 (I > 2σ(I)) and wR2 
was 0.2995 (all data). 
c) Refinement details. Distance restraints were imposed on the disordered PF6— anions and the 
hydrogens on the nitrogens in the porphyrin. The enhanced rigid-bond restraint (SHELX keyword 
RIGU) was applied globally.  
d) Solvent treatment details. The solvent masking procedure as implemented in Olex2 was used to 
remove the electronic contribution of solvent molecules from the refinement. As the exact solvent 
content is not known, only the atoms used in the refinement model are reported in the formula 
here. Total solvent accessible volume / cell = 1365.9 Å3 [15.4%] Total electron count / cell = 288.2.  
 
2) C60ÌTPPCage•8PF6 
a) Methods. A solution of TPPCage•8PF6 (1 mg) in DMF (0.5 mL) and a solution of C60 (~0.3 
mg) in PhMe (0.5 mL) were mixed, the mixture was passed through a 0.45-µm filter into VWR 
culture tubes. The tubes were placed in one 20-mL vial containing iPr2O (~3 mL) and the vial was 
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capped. Slow vapor diffusion of iPr2O into the solution of C60 and TPPCage•8PF6 in 1:1 
DMF/PhMe over the period of 7 d yielded dark brown single crystals of C60ÌTPPCage•8PF6. A 
suitable crystal was selected and the crystal was mounted on a MITIGEN holder in Paratone oil 
on a Kappa Apex 2 diffractometer. The crystal was kept at 100.0 K during data collection. Using 
Olex2S3, the structure was solved with the XMS5 structure solution program using Dual Space and 
refined with the XLS5 refinement package using Least Squares minimisation. The solid-state 
superstructure of C60 Ì TPPCage•8PF6 is shown in Figure S26b. 
b) Crystal data. Monoclinic, space group C2/c (no. 15), a = 26.125(4), b = 22.632(4), c = 35.143(5) 
Å, β = 109.353(10)°, V = 19604(5) Å3, Z = 4, T = 100.0 K, µ(CuKα) = 1.569 mm-1, Dcalc = 1.350 
g/mm3, 34816 reflections measured (5.33 ≤ 2Θ ≤ 88.984), 7704 unique (Rint = 0.1612, Rsigma = 
0.1196) which were used in all calculations. The final R1 was 0.0915 (I > 2σ(I)) and wR2 was 
0.3064 (all data).  
c) Refinement details. Distance restraints were imposed on the disordered PF6— molecule as well 
as the enhanced rigid-bond restraint (SHELX keyword RIGU).  
d) Solvent treatment details. The solvent masking procedure as implemented in Olex2 was used to 
remove the electronic contribution of solvent molecules from the refinement. As the exact solvent 
content is not known, only the atoms used in the refinement model are reported in the formula here. 
Total solvent accessible volume / cell = 3915.6 Å3 [20.0%] Total electron count / cell = 1220.0.  
 
3) C70ÌTPPCage•8PF6 
a) Methods. A solution of TPPCage•8PF6 (1 mg) in DMF (0.5 mL) and a solution of C70 (~0.3 
mg) in PhMe (0.5 mL) were mixed, the mixture was passed through a 0.45-µm filter into VWR 
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culture tubes. The tubes were placed in one 20-mL vial containing iPr2O (~3 mL) and the vial was 
capped. Slow vapor diffusion of iPr2O into the solution of C70 and TPPCage•8PF6 in 1:1 
DMF/PhMe over the period of 14 d yielded dark brown single crystals of C70ÌTPPCage•8PF6. A 
suitable crystal was selected and the crystal was mounted on a MITIGEN holder in Paratone oil 
on a Bruker Kappa APEX CCD area detector diffractometer. The crystal was kept at 100.0 K 
during data collection. Using Olex2 S3, the structure was solved with the XMS5  structure solution 
program using Dual Space and refined with the XLS5 refinement package using Least Squares 
minimization. The solid-state superstructure of C70 Ì TPPCage•8PF6 is shown in Figure S26c. 
 
b) Crystal data. Trigonal, space group P3121 (no. 152), a = 23.6016(8), c = 61.756(2) Å, V = 
29791(2) Å3, Z = 6, T = 100.0 K, µ(CuKα) = 1.567 mm-1, Dcalc = 1.373 g/mm3, 129409 reflections 
measured (4.322 ≤ 2Θ ≤ 127.444), 32729 unique (Rint = 0.0448, Rsigma = 0.0430) which were used 
in all calculations. The final R1 was 0.1479 (I > 2σ(I)) and wR2 was 0.4184 (all data).  
 
c) Refinement details. The disordered C70 was placed in an idealized positions and the second 
residue was refined with similar bond lengths. Distance restraints were imposed on the PF6— 
anions as well as the disordered ring. The enhanced rigid-bond restraint (SHELX keyword RIGU) 
was applied the same anions and disordered ring as well as the solvent molecules.  
 
d) Solvent treatment details. The solvent masking procedure as implemented in Olex2 was used to 
remove the electronic contribution of solvent molecules from the refinement. As the exact solvent 
content is not known, only the atoms used in the refinement model are reported in the formula here. 
Total solvent accessible volume / cell = 6059.8 Å3 [20.3%] Total electron count / cell = 1727.1. 
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Figure S26. Solid-state (super)structure of (a) TPPCage8+, (b) C60ÌTPPCage8+, and (c) 
C70ÌTPPCage8+ obtained from single crystal X-ray diffraction. PF6– anions and solvent 
molecules are omitted for the sake of clarity. 
 
Table S3. Summary of measured distances and angles from the solid-state 
(super)structures of TPPCage8+, C60ÌTPPCage8+, and C70ÌTPPCage8+. 
  TPPCage8+ C60ÌTPPCage8+ C70ÌTPPCage8+ 
Torsion angle j / ° 0 58 44 
Height of cage / Å 12.2 12.4 12.7 
Fullerene to porphyrin / Å N/A 2.64 2.48 
Fullerene to viologen / Å N/A 3.3 2.94 
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Figure S27. Solid-state superstructure of fullereneÌTPPCage8+ revealing a racemic 
packing by the chiral host-guest complex. 
 
Section I. DFT Calculations 
Computational Details. All DFT calculations were performed using the ORCA package.S6 The 
valence double-zeta basis sets def2-SVP were used for geometry optimization, and the valence 
triple-zeta basis sets def2-TZVP(-f) were used for computing the final energies from single-point 
calculations upon geometries optimized with B3LYP-D3/def-SVP. The resolution of identity 
RIJCOSX approximation was used to accelerate both the B3LYP-D3 and M06-2X calculations. 
The solvation effect was taken into account using the conductor-like continuum polarization 
modelS7 (C-PCM) with DMF as the solvent. The encapsulation energy is defined as the energy 
difference between the host cage molecule plus the guest molecule and the encapsulated host-guest 
complex. 
	 S27 
Table S4. Encapsulation energies (in kcal/mol) for the C60 and C70 cases. 
 
Guest B3LYP dispersion (D3) B3LYP-D3 M06-2X 
C60 −24.4 70.2 45.8 21.2 
C70 −39.5 100.5 60.9 25.4 
 
 
 
Figure S28. Optimized computational model (super)structures of (a) C60ÌTPPCage8+DFT, 
and (b) C70ÌTPPCage8+DFT determined by DFT calculations employing the B3LYP 
functional with empirical D3 dispersion correction (B3LYP-D3), and the M06-2X functional 
that includes dispersion intrinsically. Distances from the DFT optimized structures are 
provided in black, and the corresponding measurements from the solid-state structures 
are presented in red in parentheses. 
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